Loading ...

Pilot Clinical Trial of Ustekinumab in Patients With New-onset T1D

(

UST1D

)

ITN Protocol #:

ITN826AI

Branded Name:

UST1D

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Type 1 Diabetes

Current Status:

Complete

Summary:

Phase I/II Study of Ustekinumab in Patients With New-onset Type 1 Diabetes

Clinical Operations Associate Director & Manager

ITN Clinical Trial Physician

Study Personnel:

Protocol Chair

Carol Soppecsoppe@immunetolerance.org

Work: 

415-353-4879

Protocol Chair

Srinath Sanda, MDssanda@immunetolerance.org

Work: 

415-353-4414